Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab.
Na, Z., Yeo, S.P., Bharath, S.R., Bowler, M.W., Balijkcij, E., Wang, C.I., Song, H.(2017) Cell Res 27: 147-150
- PubMed: 27325296 
- DOI: 10.1038/cr.2016.77
- Primary Citation of Related Structures:  
5JXE